Home » Topics » BioWorld Science

BioWorld Science
RSS

Brain subtype-specific nicotinic receptor agonists and uses thereof described by Targacept

July 3, 2001

Potent chymase inhibitors presented by Wakunaga

July 3, 2001

Pyrimidine-based inhibitors of CD40 function reported by Sankyo

July 3, 2001

Selective beta3-adrenoceptor agonists designed at Kissei

July 3, 2001

Recent patent reveals novel antifungal, antiprotozoal sordaricin derivatives

July 3, 2001

NeoTherapeutics adds site to Neotrofin SCI study

July 3, 2001

Novavax seeks approval of Estrasorb in U.S.; expands license agreement with King

July 3, 2001

New AGE production inhibitor with promise in diabetic nephropathy

July 3, 2001

CollaGenex launches tablet formulation of Periostat

July 3, 2001

Small-molecule LFA-1 antagonist enters phase I studies

July 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...